These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2650311)

  • 1. Intravenous administration of cyclosporine for immunosuppression in heart transplant patients.
    Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Sweeney MS; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2487. PubMed ID: 2650311
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous cyclosporine for heart transplantation.
    Bolman RM; Cance CG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-dose cyclosporine A on toxicity and rejection in cardiac transplantation.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    Transplant Proc; 1987 Apr; 19(2):2847-50. PubMed ID: 3551225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation.
    Moore CK; Bristow MR; Renlund DG; Rasmussen LG; O'Connell JB
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):25-9. PubMed ID: 2349736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation].
    Morales J; Mocarquer A; James E; Aris L; Herrera L; Morales I
    Rev Med Chil; 1987 Dec; 115(12):1172-5. PubMed ID: 3332925
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M; Tazelaar HD; Billingham ME
    J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma.
    Brumbaugh J; Baldwin JC; Stinson EB; Oyer PE; Jamieson SW; Bieber CP; Henle W; Shumway NE
    J Heart Transplant; 1985 May; 4(3):307-11. PubMed ID: 3039097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract]   [Full Text] [Related]  

  • 13. A limited sampling strategy for the measurement of cyclosporine AUC.
    Johnston A; Sketris I; Marsden JT; Galustian CG; Fashola T; Taube D; Pepper J; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1345-6. PubMed ID: 2349694
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from cyclosporine to azathioprine in heart transplant recipients.
    Stevens L; Halbrook H; Berron K; Spears C; Hormuth D
    J Heart Transplant; 1988; 7(2):119-22. PubMed ID: 3284982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term effects of cyclosporine in heart transplant patients.
    Kaye MP
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):12-4. PubMed ID: 2349733
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of cardiac rejection in heart and heart-lung transplantation.
    Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
    J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cardiac transplant rejection without massive immunosuppression.
    Michler RE; Smith CR; Drusin RE; Reison DS; Hickey TJ; Lamb J; Reemtsma K; Rose EA
    Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of moderate heart allograft rejection with cyclosporine.
    Radovancevic B; Frazier OH
    J Heart Transplant; 1986; 5(4):307-11. PubMed ID: 3114444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.